M1 Kliniken AG (ETR:M12)

Market Cap	264.22M
Revenue (ttm)	333.27M
Net Income (ttm)	16.76M
Shares Out	18.56M
EPS (ttm)	0.91
PE Ratio	15.65
Forward PE	16.56
Dividend	0.50 (3.51%)
Ex-Dividend Date	n/a

Volume	9,639
Average Volume	8,491
Open	14.80
Previous Close	14.24
Day's Range	14.62 - 14.92
52-Week Range	12.20 - 22.40
Beta	0.90
RSI	45.94
Earnings Date	May 22, 2025

About M1 Kliniken AG

M1 Kliniken AG, together with its subsidiaries, provides aesthetic medicine and plastic surgery services in Germany, Austria, the Netherlands, Switzerland, the United Kingdom, Croatia, Hungary, Bulgaria, Romania, and Australia. It operates in two segments, Beauty and Trade. The Beauty segment provides aesthetic surgery services, such as breast augmentation, eyelid lifts, and liposuction; and other aesthetic medical treatment services, including injections with hyaluronic acid and botulinum toxin. This segment also manages a private clinic for p...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 2007
• Employees: 219
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: M12

Financial Performance

In 2023, M1 Kliniken AG's revenue was 316.32 million, an increase of 10.88% compared to the previous year's 285.29 million. Earnings were 10.27 million, an increase of 137.98%.